Aldeyra Therapeutics, Inc.
ALDXNasdaqCIK 1341235HealthcareFiscal year ends Dec 31
Reports and events: 252 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-2903:01 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-405954 |
| 2026-08-0616:02 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001341235-26-000010 |
| 2026-07-3017:07 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-326337 |
| 2026-07-1516:46 ET | 8-K | 8.01 Other events | 0001193125-26-304880 |
| 2026-06-1020:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-264514 |
| 2026-05-0716:02 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001341235-26-000006 |
| 2026-05-0108:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-199157 |
| 2026-04-2716:10 ET | DEF 14A | Proxy statementPeriod 2025-06-10 | 0001193125-26-182099 |
| 2026-04-2017:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-164198 |
| 2026-04-0116:25 ET | 8-K | 8.01 Other events | 0001193125-26-137984 |
| 2026-03-1708:39 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-109511 |
| 2026-02-2716:47 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-083012 |
| 2025-12-3117:07 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-338394 |
| 2025-12-1619:49 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-319638 |
| 2025-11-1307:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-278804 |
| 2025-11-0516:16 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-266989 |
| 2025-10-2807:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-252200 |
| 2025-08-1907:00 ET | 8-K | 9.01 Financial statements and exhibits | 0000950170-25-109932 |
| 2025-08-0716:03 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-104971 |
| 2025-07-1707:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-064869 |
| 2025-06-2607:01 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-058035 |
| 2025-06-1707:03 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-054949 |
| 2025-06-1116:01 ET | 8-K | 5.07 Shareholder vote results | 0000950170-25-084820 |
| 2025-05-1417:13 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-071602 |
| 2025-05-0607:01 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-113275 |
| 2025-04-2516:19 ET | DEF 14A | Proxy statementPeriod 2025-06-10 | 0001193125-25-096899 |
| 2025-04-1716:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-25-032947 |
| 2025-04-0316:50 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-072424 |
| 2025-03-2817:19 ET | 10-K/A | Annual report, amendedPeriod 2024-12-31 | 0000950170-25-046946 |
| 2025-02-2816:36 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-030102 |
| 2024-11-1807:01 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-099333 |
| 2024-11-0716:02 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-123248 |
| 2024-10-0307:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-084844 |
| 2024-10-0216:10 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-24-231158 |
| 2024-09-0309:02 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-24-211645 |
| 2024-08-0807:06 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-066327 |
| 2024-08-0116:11 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-24-191518 |
| 2024-08-0116:03 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-089238 |
| 2024-06-2007:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-054003 |
| 2024-06-1307:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-24-052234 |
| 2024-06-0716:07 ET | 8-K | 5.07 Shareholder vote results | 0001193125-24-157328 |
| 2024-05-0216:03 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-052056 |
| 2024-04-2507:01 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-035953 |
| 2024-04-2216:11 ET | DEF 14A | Proxy statementPeriod 2024-06-04 | 0001193125-24-104862 |
| 2024-03-2807:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-24-026871 |
| 2024-03-0716:06 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-027933 |
| 2024-02-1316:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001157523-24-000230 |
| 2024-01-0407:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001157523-24-000014 |
| 2023-12-2116:06 ET | 8-K | 8.01 Other events | 0001193125-23-301185 |
| 2023-12-1907:05 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001157523-23-001841 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:11 ET. Listed shows no prices and gives no investment advice.